Table 1 Characteristics of the included articles
Study | Year | Sample size | Sex (M/F) | Mean age (years) | BMI (kg/m2) | Cemented | Prosthesis type | Patellar resurfacing | Thromboprophylaxis | Hemostasis | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | T | NT | T | NT | T | NT | T | NT | Â | Â | Â | Â | Â |
P. Aglietti | 1999 | 10 | 10 | 3/7 | 4/6 | 70.0 | 68.0 | 27.9 | 27.3 | Y | M.B.K, Zimmer | NS | NS | NS |
H.M. Wakankar | 1999 | 37 | 40 | 11/26 | 14/26 | 72.5 | 71.8 | NS | NS | Y | Insall-Burstein | Y | Warfarin | NS |
Eric Vanden | 2002 | 40 | 40 | 9/31 | 16/24 | 72.5 | 68.5 | NS | NS | Y | Wallaby I, Protek | NS | NS | NS |
G. Matziolis | 2005 | 10 | 10 | 2/8 | 3/7 | 72.4 | 76.6 | 28.3 | 29.5 | Y | PFC Sigma, Depuy | N | NS | NS |
K. Kageyama | 2007 | 11 | 11 | 2/9 | 2/9 | 73.0 | 76.0 | 26.6 | 24.7 | NS | NS | NS | NS | NS |
Ta-Wei Tai | 2012 | 36 | 36 | 9/27 | 8/28 | 72.1 | 71.5 | 28.6 | 27.9 | Y | Genesis II or U2 | NS | NS | NS |
Hakan Ledin | 2012 | 25 | 23 | 10/15 | 9/14 | 70.0 | 71.0 | 29.0 | 28.0 | Y | NexgenCR, Zimmer | NS | Low-molecular-weight | NS |
David Liu | 2014 | 10 | 10 | 7/3 | 9/1 | 67.0 | 70.0 | 25.6 | 27.1 | Y | NS | Y | NS | NS |
Ashir Ejaz | 2014 | 33 | 31 | 18/15 | 17/14 | 68.0 | 68.0 | 25.0 | 25.0 | Y | NexgenCR, Zimmer | Y | Rivaroxaban | Tranexamic |
Ashir Ejaz | 2015 | 31 | 31 | 16/15 | 17/14 | 68.3 | 68.2 | 25.1 | 25.2 | Y | NS | Y | NS | NS |
A. Douglas | 2016 | 28 | 28 | 16/12 | 16/12 | 62.0 | 62.0 | 29.0 | 29.0 | Y | NS | N | Y | NS |